Financials NEXTURNBIOSCIENCE Co., Ltd.

Equities

A089140

KR7089140008

Industrial Machinery & Equipment

End-of-day quote Korea S.E. 23:00:00 16/05/2024 BST 5-day change 1st Jan Change
4,080 KRW -0.49% Intraday chart for NEXTURNBIOSCIENCE Co., Ltd. +1.24% -26.09%

Valuation

Fiscal Period: December 2020 2021 2022 2023
Capitalization 1 124,142 200,064 65,856 51,872
Enterprise Value (EV) 1 70,223 186,026 113,268 97,500
P/E ratio -52.2 x -45.1 x -12.3 x 6.23 x
Yield - - - -
Capitalization / Revenue 12.8 x 11.8 x 2.27 x 1.26 x
EV / Revenue 7.25 x 11 x 3.91 x 2.36 x
EV / EBITDA -28.1 x -139 x -44.4 x 133 x
EV / FCF - 11,049,549 x -6,358,730 x 17,788,188 x
FCF Yield - 0% -0% 0%
Price to Book 1.31 x 2.16 x 0.61 x 0.38 x
Nbr of stocks (in thousands) 6,259 6,412 7,771 9,397
Reference price 2 19,833 31,200 8,475 5,520
Announcement Date 22/03/22 22/03/22 21/03/23 21/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023
Net sales 1 9,685 16,972 28,990 41,258
EBITDA 1 -2,503 -1,338 -2,554 731.8
EBIT 1 -3,018 -2,390 -4,362 -1,271
Operating Margin -31.16% -14.08% -15.05% -3.08%
Earnings before Tax (EBT) 1 -3,430 -3,997 -4,448 16,923
Net income 1 -2,436 -4,433 -4,688 9,681
Net margin -25.15% -26.12% -16.17% 23.46%
EPS 2 -380.0 -691.3 -690.6 885.4
Free Cash Flow - 16,836 -17,813 5,481
FCF margin - 99.19% -61.44% 13.29%
FCF Conversion (EBITDA) - - - 748.96%
FCF Conversion (Net income) - - - 56.62%
Dividend per Share - - - -
Announcement Date 22/03/22 22/03/22 21/03/23 21/03/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023
Net Debt 1 - - 47,412 45,628
Net Cash position 1 53,920 14,038 - -
Leverage (Debt/EBITDA) - - -18.57 x 62.35 x
Free Cash Flow - 16,836 -17,813 5,481
ROE (net income / shareholders' equity) - -4.68% -4.66% 7.53%
ROA (Net income/ Total Assets) - -1.25% -1.61% -0.36%
Assets 1 - 353,656 291,667 -2,708,728
Book Value Per Share 2 15,091 14,462 13,934 14,687
Cash Flow per Share 2 8,219 3,218 1,370 1,462
Capex 1 1,215 468 216 1,077
Capex / Sales 12.54% 2.76% 0.75% 2.61%
Announcement Date 22/03/22 22/03/22 21/03/23 21/03/24
1KRW in Million2KRW
Estimates
  1. Stock Market
  2. Equities
  3. A089140 Stock
  4. Financials NEXTURNBIOSCIENCE Co., Ltd.